The overall goals of this proposal are to elucidate the mechanisms of cytotoxicity and resistance to taxol in human myeloid leukemia versus normal bone marrow progenitor cells (NBMPC). These studies are based on our recent findings that taxol induces the gene directed and active form of apoptotic death in human leukemic cells, which is significantly retarded in the leukemic cells over-expressing BCL-2 oncogene. In addition, leukemic cells over-expressing MDR-1 gene encoded membrane P-glycoprotein (PGP) are resistant to intracellular taxol accumulation and apoptosis. In the proposed studies we will examine whether clinically achievable concentrations of taxol produce the internucleosomal DNA fragmentation and morphologic features of apoptosis in patient derived AML blasts. Taxol induced apoptosis along with the intracellular microtubular bundling and cell cycle G2/M arrest will be correlated with taxol mediated inhibition of the clonogenic survival of AML blasts. Modulation of apoptosis by previously described alterations in protein phosphorylations will also be tested to determine their role in the molecular signalling of taxol induced apoptosis. This may also indicate whether a specific modulation of protein phosphorylation would augment taxol induced apoptosis in AML blasts. BCL-2 and c-myc expression in AML blasts will be determined and correlated with the degree of taxol induced apoptosis. Also, in a BCL-2 transfected and over-expressing pre-B leukemia cell line in which taxol induced apoptosis is significantly retarded, we will determine whether taxol produces intracellular microtubular bundling and cell cycle G2M arrest, and if so whether the growth arrested cells eventually die by apoptosis with declining levels of BCL-2 expression. To examine mechanisms of resistance to intracellular taxol accumulation and taxol induced apoptosis, we will sequentially examine patient derived AML blasts at diagnosis and relapse for MDR-1 and BCL-2 expressions. These will be correlated with taxol induced intracellular microtubule bungling, cell cycle G2/Marrest, apoptosis and the inhibition of clonogenic survival of AML blasts. In purified CD34+ NBMPC as well, we will examine taxol induced microtubule and cytokinetic changes and features of apoptosis. These will be correlated with BCL-2 and MDR-1 expression in NBMPC. Finally, we will compare the effects of hemopoietic growth factors (HGFs) G-CSF and pIXY 321 on taxol mediated inhibition of the clonogenic survival of normal CFU-GM and CFU- GEMM versus AML blasts (L-CFU). These studies will help elucidate the mechanisms of action and resistance to taxol induced apoptotic cell death in AML blasts versus NBMPC and establish the role of HGFs in reducing host bone marrow toxicity of taxol.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA063382-01
Application #
2105188
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1994-04-01
Project End
1997-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Medical University of South Carolina
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Guo, Fei; Nimmanapalli, Ramadevi; Paranawithana, Shanthi et al. (2002) Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis. Blood 99:3419-26
Yamaguchi, Hirohito; Paranawithana, Shanthi R; Lee, Michael W et al. (2002) Epothilone B analogue (BMS-247550)-mediated cytotoxicity through induction of Bax conformational change in human breast cancer cells. Cancer Res 62:466-71
Kim, C N; Bhalla, K; Kreitman, R J et al. (1999) Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor and Ara-C exert synergistic toxicity against human AML HL-60 cells. Leuk Res 23:527-38
Huang, Y; Ray, S; Reed, J C et al. (1997) Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells. Breast Cancer Res Treat 42:73-81
Huang, Y; Ibrado, A M; Reed, J C et al. (1997) Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells. Leukemia 11:253-7
Ibrado, A M; Huang, Y; Fang, G et al. (1996) Bcl-xL overexpression inhibits taxol-induced Yama protease activity and apoptosis. Cell Growth Differ 7:1087-94
Ray, S; Bullock, G; Nunez, G et al. (1996) Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis. Cell Growth Differ 7:1617-23
Bullock, G; Ray, S; Reed, J C et al. (1996) Intracellular metabolism of Ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bcl-2 protein. Leukemia 10:1731-40
Bullock, G; Ray, S; Reed, J et al. (1995) Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells. Clin Cancer Res 1:559-64
Ponnathpur, V; Ibrado, A M; Reed, J C et al. (1995) Effects of modulators of protein kinases on taxol-induced apoptosis of human leukemic cells possessing disparate levels of p26BCL-2 protein. Clin Cancer Res 1:1399-406

Showing the most recent 10 out of 12 publications